Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS) - Bellingan, G; Jacono, F; Bannard-Smith, J (American Thoracic Society, 2019)